nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.226	0.325	CbGbCtD
Bicalutamide—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.188	0.27	CbGbCtD
Bicalutamide—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.172	0.247	CbGbCtD
Bicalutamide—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.109	0.157	CbGbCtD
Bicalutamide—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0414	CcSEcCtD
Bicalutamide—Enzalutamide—ALB—focal segmental glomerulosclerosis	0.00705	1	CrCbGaD
Bicalutamide—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.00672	0.0226	CcSEcCtD
Bicalutamide—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00656	0.0221	CcSEcCtD
Bicalutamide—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.00656	0.0221	CcSEcCtD
Bicalutamide—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00656	0.0221	CcSEcCtD
Bicalutamide—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.00571	0.0192	CcSEcCtD
Bicalutamide—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00539	0.0181	CcSEcCtD
Bicalutamide—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00534	0.0179	CcSEcCtD
Bicalutamide—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00507	0.017	CcSEcCtD
Bicalutamide—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.00494	0.0166	CcSEcCtD
Bicalutamide—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0049	0.0165	CcSEcCtD
Bicalutamide—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.015	CcSEcCtD
Bicalutamide—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00437	0.0147	CcSEcCtD
Bicalutamide—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00425	0.0143	CcSEcCtD
Bicalutamide—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00422	0.0142	CcSEcCtD
Bicalutamide—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00411	0.0138	CcSEcCtD
Bicalutamide—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00409	0.0137	CcSEcCtD
Bicalutamide—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00401	0.0135	CcSEcCtD
Bicalutamide—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00401	0.0135	CcSEcCtD
Bicalutamide—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.0037	0.0125	CcSEcCtD
Bicalutamide—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.0124	CcSEcCtD
Bicalutamide—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.0036	0.0121	CcSEcCtD
Bicalutamide—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00358	0.012	CcSEcCtD
Bicalutamide—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.0035	0.0118	CcSEcCtD
Bicalutamide—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00345	0.0116	CcSEcCtD
Bicalutamide—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.0115	CcSEcCtD
Bicalutamide—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.0112	CcSEcCtD
Bicalutamide—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00331	0.0111	CcSEcCtD
Bicalutamide—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.0107	CcSEcCtD
Bicalutamide—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.0104	CcSEcCtD
Bicalutamide—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.01	CcSEcCtD
Bicalutamide—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00995	CcSEcCtD
Bicalutamide—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.00986	CcSEcCtD
Bicalutamide—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00285	0.00958	CcSEcCtD
Bicalutamide—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.00954	CcSEcCtD
Bicalutamide—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.00954	CcSEcCtD
Bicalutamide—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.00923	CcSEcCtD
Bicalutamide—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.00872	CcSEcCtD
Bicalutamide—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00853	CcSEcCtD
Bicalutamide—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.00841	CcSEcCtD
Bicalutamide—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00824	CcSEcCtD
Bicalutamide—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00821	CcSEcCtD
Bicalutamide—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.00804	CcSEcCtD
Bicalutamide—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.00774	CcSEcCtD
Bicalutamide—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00752	CcSEcCtD
Bicalutamide—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00743	CcSEcCtD
Bicalutamide—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00218	0.00732	CcSEcCtD
Bicalutamide—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00728	CcSEcCtD
Bicalutamide—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00726	CcSEcCtD
Bicalutamide—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00721	CcSEcCtD
Bicalutamide—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.00715	CcSEcCtD
Bicalutamide—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00707	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.00703	CcSEcCtD
Bicalutamide—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.00703	CcSEcCtD
Bicalutamide—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00699	CcSEcCtD
Bicalutamide—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00697	CcSEcCtD
Bicalutamide—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00697	CcSEcCtD
Bicalutamide—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00684	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00678	CcSEcCtD
Bicalutamide—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00676	CcSEcCtD
Bicalutamide—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00673	CcSEcCtD
Bicalutamide—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00647	CcSEcCtD
Bicalutamide—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00645	CcSEcCtD
Bicalutamide—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00644	CcSEcCtD
Bicalutamide—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00639	CcSEcCtD
Bicalutamide—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00636	CcSEcCtD
Bicalutamide—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.00631	CcSEcCtD
Bicalutamide—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.0062	CcSEcCtD
Bicalutamide—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00584	CcSEcCtD
Bicalutamide—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.0058	CcSEcCtD
Bicalutamide—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00578	CcSEcCtD
Bicalutamide—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00575	CcSEcCtD
Bicalutamide—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00569	CcSEcCtD
Bicalutamide—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00564	CcSEcCtD
Bicalutamide—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.0056	CcSEcCtD
Bicalutamide—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00552	CcSEcCtD
Bicalutamide—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.0055	CcSEcCtD
Bicalutamide—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00544	CcSEcCtD
Bicalutamide—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00539	CcSEcCtD
Bicalutamide—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00518	CcSEcCtD
Bicalutamide—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.00512	CcSEcCtD
Bicalutamide—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00489	CcSEcCtD
Bicalutamide—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00484	CcSEcCtD
Bicalutamide—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00477	CcSEcCtD
Bicalutamide—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00477	CcSEcCtD
Bicalutamide—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00475	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00474	CcSEcCtD
Bicalutamide—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00467	CcSEcCtD
Bicalutamide—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00461	CcSEcCtD
Bicalutamide—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00457	CcSEcCtD
Bicalutamide—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00454	CcSEcCtD
Bicalutamide—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00449	CcSEcCtD
Bicalutamide—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00448	CcSEcCtD
Bicalutamide—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00444	CcSEcCtD
Bicalutamide—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00442	CcSEcCtD
Bicalutamide—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00436	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00417	CcSEcCtD
Bicalutamide—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00414	CcSEcCtD
Bicalutamide—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00411	CcSEcCtD
Bicalutamide—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00408	CcSEcCtD
Bicalutamide—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00407	CcSEcCtD
Bicalutamide—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00403	CcSEcCtD
Bicalutamide—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00398	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00395	CcSEcCtD
Bicalutamide—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00394	CcSEcCtD
Bicalutamide—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00391	CcSEcCtD
Bicalutamide—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00391	CcSEcCtD
Bicalutamide—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00377	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00374	CcSEcCtD
Bicalutamide—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00363	CcSEcCtD
Bicalutamide—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00362	CcSEcCtD
Bicalutamide—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00362	CcSEcCtD
Bicalutamide—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00337	CcSEcCtD
Bicalutamide—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000976	0.00328	CcSEcCtD
Bicalutamide—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000963	0.00324	CcSEcCtD
Bicalutamide—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000931	0.00313	CcSEcCtD
Bicalutamide—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.0009	0.00302	CcSEcCtD
Bicalutamide—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000865	0.00291	CcSEcCtD
Bicalutamide—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000858	0.00288	CcSEcCtD
Bicalutamide—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000857	0.00288	CcSEcCtD
Bicalutamide—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000853	0.00287	CcSEcCtD
Bicalutamide—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000808	0.00272	CcSEcCtD
